RELATED APPLICATION
This application is a national stage filing under 35 U.S.C. .sctn. 371 of international application PCT/GB2012/052284, filed Sep. 14, 2012, which was published under PCT Article 21(2) in English.
This invention relates to a pharmaceutical composition comprising or consisting
This application is a National Stage application under 35 U.S.C. .sctn. 371 of International Application No. PCT/GB2017/050868, having an International Filing Date of Mar. 28, 2017, which claims the benefit of United Kingdom Application Serial No. 1605448.8 filed Mar. 31, 2016. This disclosure of